type 2 diabetes treated with metforminMiles JMLeiter LHolander PWadden Tet alDiabetes Care
Dr. Rosengren and his team experimented with 97 type-2 diabetes patients. All were treated with metformin. But one group of the patients were also given sulforaphane every day for three months. The other patients were given aplacebo. On average, th...
16,18,19 Individuals with diabetes treated with metformin showed fewer age-related chronic diseases such as cardiovascular disease, kidney dysfunction, and cancer.16-18 These associations may reflect the antiaging properties of metformin against the onset of disease or diabetes-associated complications. ...
Cancer Risk in Diabetic Patients Treated with Metformin: A Systematic Review and Meta-analysis. Background: A growing body of evidence has suggested that metformin potentially reduces the risk of cancer. Our objective was to enhance the precision of e... Noto,Hiroshi - 《Plos One》 被引量: ...
Aims To compare maternal and neonatal outcomes in women with gestational diabetes treated with diet, metformin and/or insulin in routine clinical practice in a single centre.Methods We analysed prospectively collected data from the National Women's Health database for all women with gestational diabete...
Of note, we did not show any attenuation of the GDF15 signal with progression when adjusting for whether the patients were treated with metformin at the time of blood sampling. In addition, we identify several proteins biomarkers to be associated with glycaemic deterioration in diabetes, including...
Although MET-treated DM patients had better cardiac function, renal function and larger BMI, Cox proportional hazard model analysis revealed that MET treatment was associated with a significantly better outcome even after the adjustment for BNP, eGFR and BMI (Table 2). Table 2 Metformin and outcome...
Intensified Diabetes Treatment and Cardiovascular Outcomes JAMA Original Investigation June 11, 2014 In a retrospective cohort study of veterans with diabetes initially treated with metformin, Roumie and coauthors compared time to acute myocardial infarction, stroke, or death in patients who added insulin...
(S)1 and Chondroitin 4-sulfate were significant metabolites hit in the glycosaminoglycan degradation metabolic pathways. The perturbed glycosaminoglycan degradation metabolic pathways correspond to a study using a sulphated glycosaminoglycan assay kit in diabetes patients treated with metformin for six months...
can be enough if the person makes significant lifestyle changes. Other signs, symptoms, and complications also may need treatment. For example, nutritional deficiencies should be corrected,heartor kidney diseasemay need to be treated, and vision must be checked for eye problemslikediabetic ...